By rpm
Inflazome closes US$17m Series A financing round from Novartis Venture Fund and Fountain Healthcare Partners to develop treatments for chronic inflammatory diseases2016-09-122016-09-14http://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.pngRedPepper Mergershttp://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.png200px200px